H. Erin Xie - 31 Jan 2024 Form 4 Insider Report for BlackRock Health Sciences Term Trust (BMEZ)

Role
Portfolio Manager
Signature
/s/ Gladys Chang as Attorney-in-Fact
Issuer symbol
BMEZ
Transactions as of
31 Jan 2024
Net transactions value
+$208,959
Form type
4
Filing time
02 Feb 2024, 17:49:30 UTC
Previous filing
02 Feb 2023
Next filing
04 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMEZ Common Stock Options Exercise +6,369 6,369 31 Jan 2024 Direct F1, F2
transaction BMEZ Common Stock Disposed to Issuer $114,203 -6,369 -100% $17.93 0 31 Jan 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMEZ Phantom Shares Award $323,162 +18,024 $17.93 18,024 31 Jan 2024 Common Stock 18,024 Direct F1, F3
transaction BMEZ Phantom Shares Options Exercise -6,369 -33% 12,739 31 Jan 2024 Common Stock 6,369 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash.
F2 As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.
F3 These phantom shares vest in equal installments on each of the first three anniversaries of the award.